Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer

SM Espinoza, HI Patil… - … Journal of Polymeric …, 2020 - Taylor & Francis
Abstract Poly-ε-caprolactone (PCL) has been the subject of extensive research in the past
few years. It is widely explored in drug delivery, where the development of nanomedicines …

Utilizing 4D printing to design smart gastroretentive, esophageal, and intravesical drug delivery systems

DB Mahmoud… - Advanced Healthcare …, 2023 - Wiley Online Library
The breakthrough of 3D printing in biomedical research has paved the way for the next
evolutionary step referred to as four dimensional (4D) printing. This new concept utilizes the …

Biomaterial-based regional chemotherapy: Local anticancer drug delivery to enhance chemotherapy and minimize its side-effects

K Krukiewicz, JK Zak - Materials Science and Engineering: C, 2016 - Elsevier
Since the majority of anticancer pharmacological agents affect not only cancer tissue but
also normal cells, chemotherapy is usually accompanied with severe side effects. Regional …

CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation

HY Seok, NS Rejinold, KM Lekshmi… - Journal of Controlled …, 2018 - Elsevier
In this study, we developed novel hyaluronic acid cross-linked zein nanogels (HA-Zein NGs)
to deliver the potential anticancer agent curcumin (CRC), a naturally occurring …

Hypoxia-active nanoparticles used in tumor theranostic

Y Wang, W Shang, M Niu, J Tian… - International journal of …, 2019 - Taylor & Francis
Hypoxia is a hallmark of malignant tumors and often correlates with increasing tumor
aggressiveness and poor treatment outcomes. Therefore, early diagnosis and effective …

Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer

HY Yoon, HM Yang, CH Kim, YT Goo… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Intravesical instillation is preferred over the systemic route of administration, as
an efficient route of drug administration to treat bladder cancer. However, the periodic …

Urothelium-adherent, ion-triggered liposome-in-gel system as a platform for intravesical drug delivery

S GuhaSarkar, P More, R Banerjee - Journal of Controlled Release, 2017 - Elsevier
Instillations of therapeutic agents into the urinary bladder have limited efficacy due to drug
washout and inadequate attachment to and penetration into the bladder wall. Instilled …

Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration

C Varan, H Wickström, N Sandler, Y Aktaş… - International journal of …, 2017 - Elsevier
Personalized medicine is an important treatment approach for diseases like cancer with high
intrasubject variability. In this framework, printing is one of the most promising methods since …

[HTML][HTML] Chitosan/β-glycerophosphate in situ gelling mucoadhesive systems for intravesical delivery of mitomycin-C

OM Kolawole, WM Lau, VV Khutoryanskiy - International Journal of …, 2019 - Elsevier
The development of mucoadhesive in situ gelling formulations for intravesical application
may improve the therapeutic outcomes of bladder cancer patients. In this work, chitosan/β …

The progress of chitosan-based nanoparticles for intravesical bladder cancer treatment

C Yu, S Wang, WF Lai, D Zhang - Pharmaceutics, 2023 - mdpi.com
Bladder cancer (BC) is the most frequently occurring cancer of the urinary system, with non-
muscle-invasive bladder cancer (NMIBC) accounting for 75–85% of all the bladder cancers …